Factory Supply API Riluzole Powder CAS 1744-22-5 For Antiepileptic

Factory Supply API Riluzole Powder CAS 1744-22-5 For Antiepileptic

Min.Order / FOB Price:Get Latest Price

5 Gram	Negotiable

5 Gram

Negotiable

Min.Order :5 Gram
Purity: 99% min
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Riluzole Riluzole Powder 1744-22-5

Quick Details

Appearance: White powder
Application:Animal Pharmaceuticals
PackAge:> 1kg: Packed with aluminium bags with ziplock bags inside. > 25kg: Packed with paper drum with double plastic bags inside.
ProductionCapacity:10000|Kilogram|Day
Storage:Stay in cool&dry place
Transportation:CNF/CPT/CIF/FOB

Superiority:

XAZB Biotech Co., Ltd is specialized in researching, producing and selling herbal extract and API powder, which are mainly used in nutraceutical, cosmetic, beverage and food additives etc.
Owing plant base, extracting and purifying in GMP workshop, concentrating on the quality and cost each link. That XAZB Biotech is aiming of benefiting the world with lowest price but best products.
We are keeping overcritical on the quality and persisting in the profession all the time. XAZB owns two standardized production workshops, advanced multifunction extractors and juice concentrate equipment, covering 12,000m2. annual dried material processed 950MT, monthly production ability 60MT. 32 scientists are in R&D team. We have strict QC standards and perfect quality guarantee system, GMP certified, also SO9001 and Halal certified.
We also build an integrative marketing center in Xi'an city, China, involving in research, test, sale and service. With full qualification and exporting experience, our products are widely sold to more than 40 countries from Europe, America, Southeast Asia, Oceania and so on.

Details:

Name:Riluzole
Cas No:1744-22-5
MF:C8H5F3N2OS
Use:amyotrophic lateral sclerosis
Appearance:white powder

Riluzole is a drug used to treat amyotrophic lateral sclerosis. It delays the onset of ventilator-dependence or tracheostomy in selected patients and may increase survival by approximately 3–5 months.
Riluzole preferentially blocks TTX sensitive sodium channels, which are associated with damaged neurons. This reduces influx of calcium ions and indirectly prevents stimulation of glutamate receptors. Together with direct glutamate receptor blockade, the effect of the neurotransmitter glutamate on motor neurons is greatly reduced.
However, the action of riluzole on glutamate receptors has been controversial, as no binding of the molecule has been shown on any known receptor. In addition, as its antiglutamate action is still detectable in the presence of sodium channel blockers, it is also uncertain whether or not it acts via this way. Rather, its potent glutamate uptake activator activity seems to mediate many of its effects.

Function

Treating patients with amyotrophic lateral sclerosis (ALS, Lou Gehrig disease) to prolong survival and/or to delay the need for surgery to help breathing (tracheostomy). It may also be used for other conditions as determined by your doctor.

Riluzole is a benzothiazole. Exactly how riluzole works is not known. It may prevent further damage to certain brain cells (motor neurons) responsible for controlling muscle function.

View All

Visit Store

Factory Supply API ...